A quantitative atlas of polyadenylation in five mammals
Merck & Co., Inc., Rahway, NJ, USA (United States) · Institute of Informatics of the Slovak Academy of Sciences · +2 more institutions
Abstract
We developed PolyA-seq, a strand-specific and quantitative method for high-throughput sequencing of 3' ends of polyadenylated transcripts, and used it to globally map polyadenylation (polyA) sites in 24 matched tissues in human, rhesus, dog, mouse, and rat. We show that PolyA-seq is as accurate as existing RNA sequencing (RNA-seq) approaches for digital gene expression (DGE), enabling simultaneous mapping of polyA sites and quantitative measurement of their usage. In human, we confirmed 158,533 known sites and discovered 280,857 novel sites (FDR
Citation impact
- FWCI
- —
- Percentile
- —
- References
- 55
Authors
9- ADAdnan DertiCorresponding
Merck & Co., Inc., Rahway, NJ, USA (United States), Institute of Informatics of the Slovak Academy of Sciences
- PWPhilip W. Garrett-Engele
Biomark (United States), GenProMarkers (United States)
- KDKenzie D. MacIsaac
Merck & Co., Inc., Rahway, NJ, USA (United States)
- RSRichard Stevens
Biomark (United States), GenProMarkers (United States)
- SSShreedharan Sriram
Institute of Informatics of the Slovak Academy of Sciences
Topics & keywords
- Polyadenylation
- Biology
- Gene
- Genetics
- Computational biology
- Three prime untranslated region
- RNA
- Transcriptome